Skip to main content
. 2015 Jul 27;20(6):463–475. doi: 10.3109/13625187.2015.1068934

Table 2. Percentage change from baseline at treatment cycle 3 day 24 for carrier proteins, lipoproteins, bone biomarkers, and growth and steroid endocrine parameters (ITT population).

Parameter 5 mg
E4/DRSP
n = 17
10 mg
E4/DRSP
n = 19
20 μg
EE/DRSP
n = 20
5 mg
E4/LNG
n = 18
10 mg
E4/LNG
n = 17
20 mg
E4/LNG
n = 18
SHBG 7.9 (26.2) 44.5 (34.1) 306.3 (117.7) − 69.0 (11.8) − 64.8 (11.9) − 44.2 (18.0)
CBG 17.1 (16.6) 28.1 (19.6) 170.3 (75.6) − 6.9 (17.2) 5.9 (13.3) 25.2 (25.0)
Ceruloplasmin 8.2 (12.2) 16.1 (11.1) 69.0 (22.9) − 5.4 (14.6) 0.7 (9.9) 16.2 (6.1)
HDL-cholesterol 8.1 (14.0) 5.6 (11.5) 15.2 (11.3) − 16.9 (20.7) − 11.9 (14.1) − 19.0 (10.9)
LDL-cholesterol 6.7 (20.7) 6.3 (18.3) − 9.2 (22.1) − 5.9 (16.1) − 13.8 (20.2) 8.9 (17.9)
Total cholesterol 5.2 (9.8) 5.0 (9.6) 4.9 (10.3) − 12.8 (9.1) − 15.5 (14.4) − 7.6 (9.1)
Triglycerides 6.4 (36.7) 10.0 (48.5) 61.2 (51.2) − 24.6 (33.7) − 29.7 (26.5) − 27.4 (16.5)
ASAT/SGOT − 4.0 (11.9) 2.0 (22.1) − 9.6 (25.6) − 11.6 (24.9) − 12.4 (21.9) − 13.3 (18.6)
Alkaline phosphatase − 11.3 (6.6) − 17.6 (8.6) − 20.6 (11.8) − 7.5 (12.5) − 5.8 (14.9) − 4.7 (12.5)
γGT − 4.8 (18.5) − 8.2 (14.6) − 11.0 (20.9) − 0.6 (19.8) 3.6 (16.0) 2.7 (17.7)
C-telopeptide − 8.6 (16.8) − 13.4 (20.2) − 34.9 (17.8) − 6.4 (22.5) − 12.4 (23.0) − 22.4 (18.8)
Osteocalcin − 10.4 (11.1) − 16.3 (11.9) − 22.3 (11.7) − 4.1 (16.6) 0.8 (19.7) − 13.0 (16.1)
IGF-I − 5.9 (10.8) − 11.5 (17.7) − 41.9 (14.0) 1.4 (7.4) 3.4 (20.0) − 8.8 (12.0)
IGF-II − 0.7 (8.4) − 2.3 (13.1) 4.7 (7.7) − 0.7 (9.4) 4.8 (18.6) − 2.2 (6.9)
IGFBP-1 21.1 (52.3) 0.0 (30.6) 190.9 (245.0) − 7.5 (46.7) 56.5 (251.5) 41.9 (83.8)
IGFBP-3 7.4 (8.0) 1.4 (11.0) 3.9 (12.6) 1.3 (12.4) 2.0 (12.9) 16.3 (11.0)
GH 100.0 (191.6) 314.1 (722.4) 238.4 (508.4) 173.9 (755.1) 357.5 (750.3) 467.7 (1191.3)

Values are mean (SD) percentage change.